CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Option exercise General Counsel acquired 32,000 shares (option exercise)
- 4 Grant or award Chief Executive Officer acquired 252,400 shares (grant or award)
- 8-K Event Material agreement
- S-3ASR Offering Registration Statement
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Open-market sale Chief Medical Officer sold 19,500 shares at an average $29.99 ($584,738)
- 8-K Event Material agreement
- 5 Insider Annual Insider Trading Report
- 4 Option exercise Chief Executive Officer acquired 40,624 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Returned to the company Chief Executive Officer returned 551,197 shares (to the company)
- 4 Option exercise Chief Executive Officer acquired 2,501 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
Page 17 of 69 · 1,363 filings